News - PharmaTimes
WEB4 days ago · Theramex’s Eladynos recommended by NICE for post-menopausal bone disease. 20th Aug 2024. Osteoporosis currently affects 3.8 million people in the UK, particularly impacting older women after menopause.
Pharmaceuticals in 2022 - PharmaTimes
WEBDec 7, 2021 · Published in PharmaTimes magazine - December 2021. The pharma industry has been pivotal during the pandemic and this focus looks set to continue into 2022. The coronavirus pandemic has not only boosted many pharmaceutical companies’ revenues, it has also bolstered their reputations. The value of …
Magazines - PharmaTimes
WEBPharmaTimes Magazine. PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis. PharmaTimes print and digital ...
Connecting the dots - PharmaTimes
WEBJun 3, 2021 · 2021 trends in global clinical trial execution. The pharmaceutical industry, with the clinical trial process at its core, operates on a truly global scale, conducting studies to determine the safety and efficacy of therapies and vaccines, fundamental to the advancement of human health.
The ecosystem overtakes the producers in pharma and life sciences
WEBDec 7, 2021 · In June, Danaher joined other service companies in the top ten by announcing its $9.6bn acquisition of Aldevron, buying out PE houses EQT and TA Associates. Aldevron produces plasmid DNA, mRNA and proteins, supporting pharma and biotech clients in research, clinical and commercial stage work. The acquisition will expand Danaher’s capabilities ...
Deal or no deal - PharmaTimes
WEBMar 14, 2024 · Approaches to M&As in pharma points to each company’s philosophy. According to GlobalData’s Q4 2023 update, there were 426 M&A deals announced in the global pharmaceutical industry over the year, worth a total of USD 84.2Bn.
A new era beckons - PharmaTimes
WEBOct 2, 2023 · The global pharma industry continues to make leaps and bounds in the race to identify new and innovative medical interventions to treat an array of modern diseases and keep the general population living well – for much longer than ever before.
World in motion - PharmaTimes
WEBMar 1, 2022 · Current market dynamics in the European life sciences sector have been radically altered by the turbulence of COVID-19. The pandemic, however, has presented unique challenges and opportunities
PharmaTimes - June 2021
WEBThis month’s PharmaTimes is packed with a variety of features centred on clinical research, the lifeblood of our industry. Our insightful front cover article delves into the key regulatory considerations on both sides of the Atlantic for starting cell and gene therapy trials (p26), while others look at the rise of genetic sequencing (p30) and 2021 trends in …
Biopharma transformed - PharmaTimes
WEB1. The need for speed. The speed of the industry response – discovering, developing, manufacturing and distributing new vaccines and therapies at scale for this novel coronavirus – has challenged our assumptions of biopharma development and manufacturing timescales. For patients, the medical community and for …